Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd.（DRTS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
drts · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$17.00
Consensus
$13.33
+43.6% upside
Low
$8.00
Median: $15 · Last Close: $9.28
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$13.33
43.6% upside
High Target
$17
83.2%
Low Target
$8
-13.8%
Current Price
$9.28
as of today
Based on analyst price targets, the DRTS stock price prediction for the next 12 months ranges from $8 to $17. The consensus DRTS price forecast of $13.33 implies 43.6% upside from the current price of $9.28.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.88 | ↓ 4.26% |
1-day model range: $8.76–$9.01. Peak: $9.01 (-4.26%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $9 | -0.2% |
| 2028 | $9 | -0.3% |
| 2029 | $9 | -0.4% |
| 2030 | $9 | -0.4% |
| 2031 | — | -0.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DRTS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-06-04 | Barclays | Maintains | Overweight→Overweight |
| 2026-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-19 | Piper Sandler | Maintains | Neutral→Neutral |
| 2026-05-12 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2026-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-11 | Citigroup | Maintains | Buy→Buy |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
Wall Street analysts have recently issued updated ratings on Alpha Tau Medical Ltd. (DRTS) stock. Of the recent 41 rating actions, 0 were upgrades and 1 were downgrades. 6 analysts currently cover DRTS.
分析师推荐趋势
DRTS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 98.3% YoY
Revenue Next Year
$12M
↑ 910.8% YoY
EPS This Year
$-0.66
EPS Next Year
$-0.51
↓ 21.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast DRTS EPS of $-0.66 for the current fiscal year, based on estimates from 4 analysts. The DRTS revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DRTS 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。DRTS 的共识目标价为 $13.33（+43.6% 上行空间），分析师共识为 Buy。
DRTS 的短期预测（明日）为 $8.88（-4.26%）。 DRTS 对 2027 年的股价预测均值为 $9。 DRTS 对 2030 年的预测区间为 $8–$11。
Alpha Tau Medical Ltd. 在 NASDAQ 上市，代码 DRTS。DRTS 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
DRTS 预测 · 8 个问题根据 6 位华尔街分析师，DRTS 的 12 个月平均目标价为 $13.33，最高 $17.00、最低 $8.00。若有图表，中位目标价可在上方查看。相对当前价 $9.28，隐含约 +43.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.